Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03993665 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 24, 2022 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 50 to confirmed 70
    • Site details revised
    v4
  2. Secondary endpoints: details revised at 1 of 4 entries
    • Site contact updated
    v3
  3. Primary completion date: Dec 2020 to Dec 2023
    • Study completion date: Dec 2023 to Dec 2028
    • Study description expanded, about 292 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators aim to validate specific MRI parameters that could improve diagnostic accuracy of metastatic cervical lymph nodes in patients with a squamous cell carcinoma in the head and neck region. Moreover, we aim to explore specific MRI parameters that could improve diagnostic accuracy of bone invasion and tumour relapse, as well as predict treatment response and survival in this target population.
Trial Details
NCT Number NCT03993665
Lead Sponsor AZ Sint-Jan AV
Conditions
(from sponsor)		 Head and Neck Cancer, Multiparametric MRI, Cervical Lymph Node, Bone Invasion, Tumour Relapse, Treatment Response
Related terms Head and Neck Neoplasms
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov